|
| U.S. Brand
Names |
|
| Neosporin® Cream [OTC]; Neosporin®
G.U.
Irrigant |

|
|
| Generic
Available |
|
|
Yes |

|
|
| Synonyms |
|
|
Polymyxin B and Neomycin |

|
|
| Pharmacological Index |
|
|
Antibiotic, Topical |

|
|
| Use |
|
|
Short-term as a continuous irrigant or rinse in the urinary bladder to
prevent bacteriuria and gram-negative rod septicemia associated with the use of
indwelling catheters; to help prevent infection in minor cuts, scrapes, and
burns |

|
|
| Pregnancy Risk
Factor |
|
|
C/D (for G.U. irrigant) |

|
|
| Contraindications |
|
|
Hypersensitivity to neomycin or polymyxin B or any component; ophthalmic use
for topical cream |

|
|
| Adverse
Reactions |
|
|
1% to 10%:
Genitourinary: Bladder irritation
Local: Burning
Neuromuscular & skeletal: Neuromuscular blockade
Otic: Ototoxicity
Renal: Nephrotoxicity |

|
|
| Drug
Interactions |
|
|
No data reported |

|
|
| Stability |
|
|
Store irrigation solution in refrigerator; aseptic prepared dilutions (1 mL/1
L) should be stored in the refrigerator and discarded after 48
hours |

|
|
| Mechanism of
Action |
|
|
Refer to individual monographs |

|
|
| Pharmacodynamics/Kinetics |
|
|
Absorption: Topical: Not absorbed following application to intact skin;
absorbed through denuded or abraded skin, peritoneum, wounds, or
ulcers |

|
|
| Usual Dosage |
|
|
Children and Adults:
Topical: Apply cream 1-4 times/day to affected area |

|
|
| Administration |
|
|
Bladder irrigant: Do not inject irrigant solution; concentrated irrigant
solution must be diluted in 1 L normal saline before administration; connect
irrigation container to the inflow lumen of a 3-way catheter to permit
continuous irrigation of the urinary bladder |

|
|
| Mental Health: Effects
on Mental Status |
|
|
None reported |

|
|
| Mental Health:
Effects on Psychiatric
Treatment |
|
|
None reported |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Patient
Information |
|
|
See individual agents. Pregnancy/breast-feeding precautions: Inform
prescriber if you are or intend to be pregnant. Consult prescriber if
breast-feeding. |

|
|
| Nursing
Implications |
|
|
Monitor urinalysis |

|
|
| Dosage Forms |
|
|
Cream: Neomycin sulfate 3.5 mg and polymyxin B sulfate 10,000 units per g
(0.94 g, 15 g)
Solution, irrigant: Neomycin sulfate 40 mg and polymyxin B sulfate 200,000
units per mL (1 mL, 20 mL) |

|
|
Copyright © 2007 Drugs Area
|